GlassScriptPhysician profile
Michael A Puniak
NPI 1861492712
$730.91
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $641 · 2020: $89.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $170.07 | 2019 | |
| Zimmer Biomet Holdings, INC. | $157.85 | 2019 | |
| Stryker Corporation | $150.00 | 2019 | |
| Innovation Technologies INC | $70.51 | 2020 | |
| Fidia Pharma USA INC. | $62.97 | 2019-2020 | |
| Depuy Synthes Sales INC. | $55.59 | 2019 | |
| Ferring Pharmaceuticals INC. | $36.85 | 2019 | |
| Sanofi-Aventis U.S. LLC | $27.07 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Puniak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.